p53-based cyclotherapy: protecting normal tissues from cytotoxic chemotherapy [ 2013 - 2016 ]

Research Grant

Researchers: Prof David Callen (Principal investigator) ,  Dr Paul Neilsen ,  Prof David Lane ,  Prof Dorothy Keefe

Brief description Cyto-toxic chemotherapy is a widely used treatment for cancer but is associated with significant side effects for the patient. These are due to the chemotherapy killing normal dividing cells in the gut, bone marrow and hair follicles. We will determine the potential of cyclotherapy in preventing these side effects. In cyclotherapy a pre-treatment temporarily stops normal cells from dividing and therefore protects them from the damage of subsequent chemotherapy.

Funding Amount $AUD 586,076.61

Funding Scheme Project Grants

Notes Standard Project Grant